Hyperfine Inc (HYPR)

Oct 01, 2026

Hyperfine’s Swoop Portable MRI System, US - Medical Device Network

Oct 01, 2026

Sep 29, 2026

Hyperfine (HYPR) Receives a Buy from Lake Street - The Globe and Mail

Sep 29, 2026

Sep 28, 2026

Hyperfine, Inc. (HYPR) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 28, 2026

Sep 28, 2026

Hyperfine appoints distributor for Kuwait and UAE markets By Investing.com - Investing.com Canada

Sep 28, 2026

Sep 28, 2026

Hyperfine appoints distributor for Kuwait and UAE markets - Investing.com India

Sep 28, 2026

Sep 28, 2026

Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets - Business Wire

Sep 28, 2026

Sep 23, 2026

Hyperfine stock reports 45 percent revenue growth - AD HOC NEWS

Sep 23, 2026

Sep 22, 2026

Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026Slideshow (NASDAQ:HYPR) 2026-06-05 - Seeking Alpha

Sep 22, 2026

Sep 22, 2026

BTIG reiterates Hyperfine stock rating on commercial progress By Investing.com - Investing.com Nigeria

Sep 22, 2026

Sep 22, 2026

HYPR Reiterated by BTIG -- Price Target Maintained at $2.00 - GuruFocus

Sep 22, 2026

Sep 22, 2026

BTIG reiterates Hyperfine stock rating on commercial progress - Investing.com

Sep 22, 2026

Sep 22, 2026

BTIG reiterates Buy rating on Hyperfine, $2 price target - TradingView

Sep 22, 2026

Sep 18, 2026

Hyperfine Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Sep 18, 2026

Sep 17, 2026

Hyperfine stock holds steady as investors await fresh signals - AD HOC NEWS

Sep 17, 2026

Sep 17, 2026

Hyperfine completes enrolment in contrast-enhanced Swoop MRI Study - Indian Pharma Post

Sep 17, 2026

Sep 16, 2026

Hyperfine CEO Maria Sainz Wins 2026 MedtechWOMEN Leadership Award - citybiz

Sep 16, 2026

Sep 16, 2026

MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award - Business Wire

Sep 16, 2026

Sep 15, 2026

Hyperfine completes enrollment in contrast MRI study By Investing.com - Investing.com Australia

Sep 15, 2026

Sep 15, 2026

Hyperfine completes enrollment in contrast MRI study - Investing.com

Sep 15, 2026

Sep 15, 2026

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents - Business Wire

Sep 15, 2026

Sep 14, 2026

Hyperfine stock maintains buy rating at BTIG on AI software update - Investing.com Canada

Sep 14, 2026

Sep 09, 2026

Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com

Sep 09, 2026

Sep 09, 2026

HYPR Q2 2026 Earnings: EPS Loss of -$0.09 Narrowly Beats Estimates, Stock Slips 1.4%Profit Recovery Report - dars.gov.et

Sep 09, 2026

Sep 04, 2026

HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Sep 04, 2026

Sep 02, 2026

Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in

Sep 02, 2026

Aug 31, 2026

Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing

Aug 31, 2026

Aug 31, 2026

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance

Aug 31, 2026

Aug 26, 2026

Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria

Aug 26, 2026

Aug 26, 2026

Hyperfine reports 3,000 scans completed in first office year - Investing.com

Aug 26, 2026

Aug 24, 2026

Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn

Aug 24, 2026

Aug 23, 2026

HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 21, 2026

Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com

Aug 21, 2026

Aug 20, 2026

BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada

Aug 20, 2026

Aug 20, 2026

BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com

Aug 20, 2026

Aug 20, 2026

Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing

Aug 20, 2026

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com

Aug 20, 2026

Aug 20, 2026

Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa

Aug 20, 2026

Aug 20, 2026

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire

Aug 20, 2026

Aug 18, 2026

Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Aug 18, 2026

Aug 15, 2026

Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn

Aug 15, 2026

Aug 14, 2026

HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn

Aug 14, 2026

Aug 13, 2026

Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn

Aug 13, 2026